Here is a "Hat Tip" to the Kaiser Daily Health Policy Report-Blog Watch which gave an honorable mention to NYSBA's "Supraspinatus" blog and linked to fellow contributor Paul Gillan's post recently-- a well written post too.
Here is the first sentence and link to one of their own posts of a biotech nature:(1).
Follow-On Biologics Legislation Could Save Billions of Dollars, According to CBO Legislation (S 1695) that would create an FDA approval pathway for follow-on biologics would reduce federal health care spending by $5.9 billion and national spending on biotechnology drugs by $25 billion over the next 10 years, according to a Congressional Budget Office analysis released this week, CQ HealthBeat reports...
On their Editorial Policy page, they write:
The Kaiser Daily Health Reports draw information from more than 300 print, Internet and multimedia sources on stories related to health policy and HIV/AIDS. The reports aim to provide objective, balanced and complete coverage of media reports in these fields. Each weekday, beginning at 6 a.m., staff members scour these sources for information relevant to each publication's audience, then excerpt and synthesize the stories, pulling out and summarizing the most important facts and quotes....
(1)http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=53012
(2)http://www.kaisernetwork.org/static/about_editorial.cfm#dr